ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,946.40
      0.04%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.38
      -1.28%
      Bitcoin
      60,922.33
      1.03%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sonnet BioTherapeutics Holdings Inc (SONN) Quote

      Sonnet BioTherapeutics Holdings Inc

      Sonnet BioTherapeutics Holdings Inc (SONN)

      NASDAQ
      1.00
      0.015
      (1.52%)
      At close: September 18 4:00PM
      Delayed by 15 minutes
      0.969
      -0.031
      ( -3.10% )
      After Hours: 6:55PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.969
      Bid
      0.9203
      Ask
      1.02
      Volume
      158,382
      0.905 Day's Range 1.03
      0.6239 52 Week Range 3.67
      Market Cap
      5.041M
      Previous Close
      0.985
      Open
      0.9969
      Last Trade
      1
      @
      1
      Last Trade Time
      18:11:57
      Financial Volume
      $ 153,576
      VWAP
      0.969657
      Average Volume (3m)
      138,887
      Shares Outstanding
      5,202,505
      Dividend Yield
      -
      PE Ratio
      -0.28
      Earnings Per Share (EPS)
      -3.62
      Revenue
      148k
      Net Profit
      -18.83M

      About Sonnet BioTherapeutics Holdings Inc

      Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Management Consulting Svcs
      Website
      www.sonnetbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2020
      Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was $0.99. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of $ 0.6239 to $ 3.67.

      Sonnet BioTherapeutics currently has 5,202,505 shares outstanding. The market capitalization of Sonnet BioTherapeutics is $5.12 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.28.

      Ask ADVFN Intelligence (AI)

      SONN Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      9 hours ago

      Form 8-K - Current report

      11 hours ago
      Edgar (US Regulatory)

      Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors

      SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE...

      11 hours ago
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      September 09 2024
      Edgar (US Regulatory)

      Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series

      PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted...

      September 04 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      August 30 2024
      Edgar (US Regulatory)

      Form ARS - Annual Report to Security Holders

      August 19 2024
      Edgar (US Regulatory)

      Form DEF 14A - Other definitive proxy statements

      August 19 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 19 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.09911.37931034480.871.020.726895470.89643129CS
      40.267738.17196634820.70131.020.6398737770.83615306CS
      120.0495.326086956520.921.020.62391388870.79538987CS
      26-1.051-52.02970297032.022.33990.6239846241.01399704CS
      52-2.651-73.23204419893.623.670.6239861981.41300318CS
      156-180.751-99.4667620515181.72224.840.6239208205988.40855368CS
      260-1914.791-99.94941955151915.764989.60.62392392455328.66894106CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      XCURExicure Inc
      $ 6.14
      (168.12%)
      		8.27M
      VEROVenus Concept Inc
      $ 1.08
      (114.93%)
      		14.12M
      ZEOZeo Energy Corporation
      $ 1.5601
      (36.85%)
      		106.93k
      RELIReliance Global Group Inc
      $ 3.11
      (19.62%)
      		220.29k
      VINOGaucho Group Holdings Inc
      $ 5.34
      (18.93%)
      		700
      SMFLSmart for Life Inc
      $ 0.415
      (-46.79%)
      		2.63M
      PGNYProgyny Inc
      $ 18.60
      (-23.90%)
      		145.22k
      RGFReal Good Food Company Inc
      $ 0.3701
      (-13.93%)
      		28.2k
      OMEXOdyssey Marine Exploration Inc
      $ 1.22
      (-12.86%)
      		4.9M
      CRMTAmericas Car Mart Inc
      $ 43.75
      (-12.43%)
      		7.11k
      VEROVenus Concept Inc
      $ 1.08
      (114.93%)
      		14.12M
      EJHE Home Household Service Holdings Ltd
      $ 0.1159
      (9.34%)
      		10.11M
      XCURExicure Inc
      $ 6.14
      (168.12%)
      		8.27M
      NVDANVIDIA Corporation
      $ 113.92
      (0.49%)
      		6.91M
      OMEXOdyssey Marine Exploration Inc
      $ 1.22
      (-12.86%)
      		4.9M

      SONN Discussion

      View Posts
      Clemdane Clemdane 2 weeks ago
      Big jump today!
      👍️0
      Awl416 Awl416 1 month ago
      Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
      👍️ 1
      Monksdream Monksdream 1 month ago
      SONN new 52=low
      👍️0
      Clemdane Clemdane 1 month ago
      Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
      👍️0
      Monksdream Monksdream 1 month ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 1 month ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 3 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 3 months ago
      SONN new 52 week low
      👍️0
      BooDog BooDog 5 months ago
      I see 76 followers here. And I have a target price of around 1.50 for support.

      GL.

      I do own shares and am looking for this to have a good future.
      👍️0
      maq1214 maq1214 6 months ago
      Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
      👍️0
      81vette 81vette 6 months ago
      23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
      👍️0
      81vette 81vette 6 months ago
      They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
      👍️0
      maq1214 maq1214 6 months ago
      Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
      👍️0
      81vette 81vette 6 months ago
      $2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
      👍️0
      81vette 81vette 6 months ago
      254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
      👍️0
      81vette 81vette 6 months ago
      5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
      👍️0
      BooDog BooDog 6 months ago
      Riding free again.
      👍️0
      Monksdream Monksdream 7 months ago
      SONN under $2
      👍️0
      crowin crowin 7 months ago
      Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
      👍️0
      maq1214 maq1214 7 months ago
      This should get exciting soon, crazy volume yesterday !
      👍️0
      BooDog BooDog 8 months ago
      IS it just greed or might this make good for another round trip? We'll see next week.
      👍️0
      BooDog BooDog 9 months ago
      Good move IMO. Surprising actually.

      On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

      https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
      👍️0
      Monksdream Monksdream 11 months ago
      SONN new 52 week low
      👍️0
      BooDog BooDog 11 months ago
      Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

      https://www.accesswire.com/viewarticle.aspx?id=796208
      👍️0
      valleybenedetto valleybenedetto 11 months ago
      Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
      👍️0
      Monksdream Monksdream 11 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 11 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 12 months ago
      SONN new 52 week low
      👍️0
      Monksdream Monksdream 12 months ago
      SONN new 52 week low
      👍️0
      valleybenedetto valleybenedetto 12 months ago
      If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
      👍️0
      Monksdream Monksdream 12 months ago
      If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
      👍️0
      valleybenedetto valleybenedetto 12 months ago
      You worry about you ok?
      👍️0
      Monksdream Monksdream 12 months ago
      You aren’t getting any money back
      Time to move on
      👍️0
      valleybenedetto valleybenedetto 12 months ago
      Not an Urban Myth ..I've already checked. They have current D and O insurance.
      👍️0
      Monksdream Monksdream 12 months ago
      Oh goddamn tell me another urban myth
      👍️0
      valleybenedetto valleybenedetto 12 months ago
      They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
      👍️0
      Monksdream Monksdream 12 months ago
      You wouldn’t get anything from a class action lawsuit
      Anyone connected to professional asset management abandoned this company long ago
      👍️0
      valleybenedetto valleybenedetto 12 months ago
      CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
      👍️0
      Monksdream Monksdream 1 year ago
      SONN new 52 week low
      👍️0
      Golden Cross Golden Cross 1 year ago
      Might be a short play here now
      👍️0
      Golden Cross Golden Cross 1 year ago
      Very true.....
      👍️0
      antman antman 1 year ago
      ...During his testimony, Elon Musk called short selling “a means for, in my opinion, bad people on Wall Street to steal money from small investors.”
      👍️0
      tw0122 tw0122 1 year ago
      Biotech CEOs are mostly Wall Street whores they get compensated to short there own companies as it’s much more lucrative. They take on that toxic financing do reverse splits as part of their regular routine. Take MULN CEO for example he has no scruples or morals nor does he hide his screwing over shareholders.
      As far as trading you play the post reverse splits at the right time with the low float and that is where the loot is made.
      Wall Street casino.
      👍️0
      valleybenedetto valleybenedetto 1 year ago
      CEO is an incompetent whore. Stock ran to 1.20 . Instead of letting it sit for 10 days and regain compliance he jammed an offering down and screwed everyone.
      👍️0
      antman antman 1 year ago
      I guess the shorts just crush all these companies and force them to do rollbacks
      👍️0
      Golden Cross Golden Cross 1 year ago
      Don't see the vote not passing now
      👍️0
      Golden Cross Golden Cross 1 year ago
      Nothing has gone right since the offering.. Time for a turnaround here... loading up
      👍️0
      Golden Cross Golden Cross 1 year ago
      Yep
      👍️0
      govprs govprs 1 year ago
      Did you see the letter to shareholders?
      👍️0
      Golden Cross Golden Cross 1 year ago
      needs something here
      👍️0

      Your Recent History

      NASDAQ
      SONN
      Sonnet BioTherapeutics
      Delayed Upgrade Clock